Radiation Oncology
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
21 Jan, 2022 | 09:36h | UTCTreatment for Brain Metastases: ASCO-SNO-ASTRO Guideline – Journal of Clinical Oncology
ASTRO issues clinical guideline on external-beam radiation therapy for primary liver cancers.
19 Jan, 2022 | 08:36h | UTCOriginal Article: External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline – Practical Radiation Oncology
Study shows many patients with metastatic cancer near the end of life still receive guideline-nonconcordant radiotherapy.
18 Jan, 2022 | 09:35h | UTCCommentary: Study: Cancer patients given high-dose radiation treatments even near end of life – UPI
ASCO Guideline: Management of stage III non–small-cell lung cancer.
18 Jan, 2022 | 09:12h | UTCManagement of Stage III Non–Small-Cell Lung Cancer: ASCO Guideline – Journal of Clinical Oncology
Systematic Review: Active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy.
8 Jan, 2022 | 22:41h | UTC
Commentary on Twitter
Systematic Review of AS for Clinically Localised PCa to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategyhttps://t.co/U9mA5KqStX@Dr_Willemse @thomas_b_lam pic.twitter.com/j6dgTaqaZs
— European Urology (@EUplatinum) January 3, 2022
RCT: Postoperative radiotherapy (PORT) did not increase disease-free survival compared with no PORT in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement.
8 Jan, 2022 | 22:38h | UTCPostoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)
Commentaries:
Post-Operative Radiotherapy Not Tied to Better Disease-Free Survival in NSCLC – MedPage Today (free registration required)
Non-inferiority randomized trial showed radiotherapy can be safely omitted in many children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma.
10 Dec, 2021 | 10:04h | UTC
Review | Past, present, and future of radiation-induced cardiotoxicity: refinements in targeting, surveillance, and risk stratification.
5 Dec, 2021 | 23:40h | UTCVideo: Radiation Therapy and Cardiovascular Disease | JACC: CardioOncology Author Discussion
Related:
Radiation‐induced cardiovascular disease: review of an underrecognized pathology.
Short review: How to diagnose and manage radiation therapy cardiotoxicity
Cohort Study: Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients with Lung Cancer
Advances in Breast Cancer Radiotherapy: Implications for Current and Future Practice.
30 Nov, 2021 | 09:55h | UTC
Commentary on Twitter
Advances in #BreastCancer radiotherapy allow shorter regimens and reduced toxicities. This #JCOOP Clinical review summarizes the latest evidence in #radonc for #bcsm @CshahMD ➡️ https://t.co/JxvU5FSQlv pic.twitter.com/GOcwAFJzRm
— Journal of Clinical Oncology (@JCO_ASCO) October 31, 2021
Long-term results of RCT: Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for patients with locally advanced rectal cancer.
19 Nov, 2021 | 10:15h | UTCChemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial – JAMA Oncology (free for a limited period)
Author Interview: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer – JAMA Oncology
Commentary on Twitter
Secondary analysis of 311 pts on ARO-12 trial of variant approaches to total neoadjuvant therapy (TNT) w/combo of chemo & concurrent chemoradiation (CRT) for rectal cancer shows best results w/up-front CRT then chemo & resection led to best results https://t.co/7cpv5cb1Fr #CRCSM pic.twitter.com/bxfz9Fi5OB
— JAMA Oncology (@JAMAOnc) November 18, 2021
M-A: Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer.
7 Nov, 2021 | 20:07h | UTC
RCT: Elective internal mammary node irradiation does not increase disease-free survival or overall survival in most women with node-positive breast cancer.
27 Oct, 2021 | 01:28h | UTCEffect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer: A Randomized Phase 3 Clinical Trial – JAMA Oncology (free for a limited period)
Commentary: No Survival Benefit for Internal Mammary Node Irradiation in Breast Cancer — Women with medially or centrally located tumors may be candidates, however, says researcher – MedPage Today (free registration required)
Commentary on Twitter
Phase III randomized study evaluated the role of internal mammary node irradiation (IMNI) in node-positive #breastcancer. IMNI did not improve the DFS in unselected patients, but did improve DFS in patients with medially or centrally located tumors https://t.co/tw4ZrHn5wn pic.twitter.com/34ye3TR9MA
— JAMA Oncology (@JAMAOnc) October 25, 2021
Radiotherapy: Clinical pearls for primary care.
22 Oct, 2021 | 10:12h | UTCRadiotherapy: Clinical pearls for primary care – Canadian Family Physician
Cohort Study: Women treated with radiation therapy for left-sided breast cancer had over twice the risk of subsequent coronary artery disease compared with women treated with radiation therapy for right-sided breast cancer.
1 Oct, 2021 | 10:21h | UTCCommentaries:
CAD in Young Women After Radiation Therapy for Breast Cancer – American College of Cardiology
Commentary on Twitter
According to a study from #JACCCardioOnc, women with left-sided breast cancer undergoing radiation therapy between 1985 and 2008 had over twice the risk of subsequent #cvCAD compared to women with right-sided breast cancer. Learn more here: https://t.co/5q9tToSSRp #CardioOnc
— American College of Cardiology (@ACCinTouch) September 22, 2021
Guidelines for the surveillance and survivorship care of patients after curative treatment of colon and rectal cancer.
16 Sep, 2021 | 09:52h | UTC
Commentary on Twitter
Clinical Practice Guidelines – Surveillance and Survivorship shown in #DCRJournal visual abstract by @ianmpaquette @JMigaly @ASCRS_1. What do you think? https://t.co/e3kADOerpq@JISBMD @ConorDelaneyMD @justinmaykel @KarimAlavi @KyleCologne @dubaicolorectal @SamAtallahMD pic.twitter.com/wOhu0Mby60
— DCRjournal (@DCRjournal) May 9, 2021
Systematic Review: Partial breast irradiation versus whole breast radiotherapy for early breast cancer.
15 Sep, 2021 | 08:46h | UTC
Commentary on Twitter
For women with early-stage #BreastCancer, how does giving radiotherapy to part of the breast compare with giving #radiotherapy to the whole breast? The latest Cochrane Review from @CochraneBCancer brings together nine studies, which involved 15,187 women: https://t.co/fVuSrSDAZM pic.twitter.com/QOufZYSH5I
— Cochrane UK (@CochraneUK) September 3, 2021
Long-term report of study evaluating radiation following surgical excision for good-risk ductal carcinoma in situ.
14 Sep, 2021 | 08:44h | UTC
Commentary on Twitter
At 15 years, NRG-RTOG 9804 "good risk" breast #DCIS trial shows advantage of radiation therapy over observation to reduce #breastcancer risk https://t.co/l5OWVOb5Dg
#JCO #BCSM #radonc @NRGOnc; @MSK_RadOnc pic.twitter.com/TPAZRheoHT— ASCO Publications (@ASCO_pubs) September 10, 2021
Radiation‐induced cardiovascular disease: review of an underrecognized pathology.
9 Sep, 2021 | 08:54h | UTC
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localized colon cancer.
26 Aug, 2021 | 08:33h | UTC
ASCO Guideline: Salivary gland hypofunction and/or xerostomia induced by nonsurgical cancer therapies.
19 Aug, 2021 | 08:50h | UTC
Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer – “This trial provides the first clinical evidence that sparing the hippocampus during PCI in patients with SCLC better preserves cognitive function”.
13 Aug, 2021 | 08:54h | UTC
RCT: Efficacy of concurrent chemoradiotherapy with S-1 vs. radiotherapy alone for older patients with esophageal cancer.
8 Aug, 2021 | 23:35h | UTCEfficacy of Concurrent Chemoradiotherapy With S-1 vs Radiotherapy Alone for Older Patients With Esophageal Cancer: A Multicenter Randomized Phase 3 Clinical Trial – JAMA Oncology (free for a limited period)
Editorial: Primary Chemoradiotherapy for Older Patients With Esophageal Cancer (free for a limited period)
Commentary: Concurrent CRT Effective for Esophageal Cancer in Older Patients — Overall survival at 2 years significantly better versus radiotherapy alone – MedPage Today (free registration required)
Commentary on Twitter
Randomized phase 3 trial of radiation with or w/o S-1 chemo in 298 older pts (median age 77) with esophageal cancer reveals concurrent chemoradiation led to significantly improved progression-free & overall survival https://t.co/wx5FG5VDUH #GICSM pic.twitter.com/SFddL53lCi
— JAMA Oncology (@JAMAOnc) August 6, 2021
ASTRO Guideline: Radiation therapy for treatment of soft tissue sarcoma in adults.
29 Jul, 2021 | 10:54h | UTCNews release: Astro Issues Clinical Guideline on Radiation Therapy for Soft Tissue Sarcoma in Adults
ESMO Guidelines: Soft tissue and visceral sarcomas.
29 Jul, 2021 | 10:53h | UTC
Radiation therapy-associated toxicity: Etiology, management, and prevention.
15 Jul, 2021 | 09:13h | UTC